<DOC>
	<DOCNO>NCT00565396</DOCNO>
	<brief_summary>The purpose study determine whether fosinopril losartan effective treatment patient Chronic Kidney Disease ( CKD ) stage 3 .</brief_summary>
	<brief_title>Effectiveness Study Fosinopril and/or Losartan Patients With Chronic Kidney Disease Stage 3</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Fosinopril</mesh_term>
	<criteria>Patients age 1875 year old Roll secondary renal disease Do use steroid immunosuppresive drug ACEI/ARB treat patient 714 day wash periodï¼ŒSiDBP &lt; 110mmHg Willing able comprehend give write informed consent Willing followup regularly Use steroid immunosuppresive drug Secondary renal disease Acute cardiocerebral disease within 6 month Post renal transplantation Pregnant/Nursing woman History hypersensitivity ACEI/ARB Refuse join clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>